CLDI

Calidi Biotherapeutics Inc

• TipRanks·6d ago

  Calidi presents new data on CLD-401 at AACR

• TipRanks·04/20 12:54

  Calidi presents new data on in situ t-cell engagers at AACR

• TipRanks·04/02 22:34

  Calidi Biotherapeutics Streamlines Board, Enhances Audit Oversight

• TipRanks·03/27 22:06

  Calidi Biotherapeutics Reports 2025 Results, Advances Oncology Pipeline

• Seeking Alpha·03/27 20:35

  Calidi Biotherapeutics GAAP EPS of -$5.95

• Dow Jones·03/27 20:25

  Press Release: Calidi Biotherapeutics Reports -2-

• NASDAQ·03/24 13:21

  Calidi Partners With Avance Clinical For CLD-401 Trial Initiation In Australia; Stock Up

• TipRanks·03/12 12:17

  Calidi presents manufacturing process for CDI-401 at BioProcessing Summit

• TipRanks·03/12 00:57

  Calidi Biotherapeutics Completes Dilutive Public Equity Offering

• Dow Jones·03/10 00:50

  Press Release: Calidi Biotherapeutics Announces Closing of $6.0 Million Underwritten Public Offering and Full Exercise of Underwriters' Over-Allotment Option

• NASDAQ·03/09 05:43

  Calidi Biotherapeutics Prices $5.2 Mln Public Offering Of Shares And Warrants

• Seeking Alpha·03/06 14:23

  Calidi Biotherapeutics prices $5.2M underwritten public offering

• NASDAQ·03/06 01:27

  Calidi Sinks On Proposed Public Offering; Shares Hit New 52-Week Low

• Seeking Alpha·03/05 23:10

  Calidi Biotherapeutics plans public offering of stock, pre-funded warrants; shares down

• TipRanks·03/05 23:00

  Calidi announces offering of units, no amount given